A · Important
[Innovative drugs and CRO concepts continue to strengthen, and many stocks such as Nanmo Biotech have reached their daily limit] On September 30, the intraday gains of innovative drugs and CRO concepts expanded, with Nanmo Biotech rising to the daily limit of 20cm, and nearshore protein and Bepsis rose by more than 10%, both hitting record highs. Previously, CanSino, Technomax, Kangchen Pharmaceuticals, and Osaikang hit their daily limit, and JianKai Technology, CSPC Innovation, Jinbo Biotech, and Yaoshi Technology were among the top gainers.
Live broadcast 🕐 2026-09-30 10:48
#Live broadcast #Innovative drugs
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[The real estate sector stabilized and rebounded, Zhongtian Services rose by the 09-30 11:10 [Main Fund Monitoring: GigaDevice’s net sales exceed 800 million yuan] September 09-30 10:56 [The computing power chip concept fluctuated and fell, VeriSilicon shares fell b 09-30 10:26 [The complete automobile sector fluctuated and rose, JAC Motors approached the d 09-30 10:11 [The volume of the two markets shrank by more than 3 billion in the first half h 09-30 10:02 [The concept of humanoid robots rebounded in shock, and Rujing Technology rose b 09-30 10:01

Comments

0/500
Captcha (click to refresh)
No comments yet